• Wednesday,October 09,2024
gecos.fr
X

Frontiers Advances in the molecular pathogenesis and cell therapy of stress urinary incontinence

$ 17.00

4.7 (396) In stock

Share

MSC-based therapy in female pelvic floor disorders, Cell & Bioscience

M-Exos as Advanced Therapeutics for Inflammation

Regenerative medicine and injection therapies in stress urinary incontinence

PDF) Advances in the molecular pathogenesis and cell therapy of stress urinary incontinence

PDF) Combined Treatment With CCR1-Overexpressing Mesenchymal Stem Cells and CCL7 Enhances Engraftment and Promotes the Recovery of Simulated Birth Injury-Induced Stress Urinary Incontinence in Rats

IJMS, Free Full-Text

Medicina, Free Full-Text

Frontiers An In Vitro Study on Extracellular Vesicles From Adipose-Derived Mesenchymal Stem Cells in Protecting Stress Urinary Incontinence Through MicroRNA-93/F3 Axis

Stem cell therapy combined with controlled release of growth factors for the treatment of sphincter dysfunction, Cell & Bioscience